Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The role of Lgr5 intestinal cancer stem cells in tumour initiation, progression and metastasis

ABSTRACT: The role of Lgr5 intestinal cancer stem cells in tumour initiation, progression and metastasis

PROVIDER: PRJNA359185 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR3950930.fastq.gz	Fastqsanger.gz
	SRR3950921.fastq.gz	Fastqsanger.gz
	SRR3950931.fastq.gz	Fastqsanger.gz
	SRR3950922.fastq.gz	Fastqsanger.gz
	SRR3950932.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 56

Similar Datasets

A Tumour-Resident Lgr5+ Stem Cell - Like Pool Drives the Establishment and Progression of Advanced Gastric Cancers

Project description:Gastric cancer is amongst the most prevalent and deadliest cancers globally. To derive mechanistic insight into the pathways governing this disease, we generated a stomach-specific Claudin18-IRES-CreERT2 mouse line to model advanced human gastric cancer and investigated the role of tumour resident Lgr5+ stem-like cells in gastric cancer. Mouse lines incorporating Cldn18-driven conditional dysregulation of the Wnt, RTK and Trp53 pathways modelled metastatic Chromosomal Instable-type gastric cancer. In parallel, we supplemented these cancer models with orthotopic transplantation of cancer organoids to derive detailed mechanistic insight into the roles of Lgr5+ cancer stem cell in gastric cancer. Here we show, we recapitulated advanced human gastric cancer in terms of disease phenotype, aberrant gene expression profile, molecular markers, and sites of distant metastases. Importantly, we established that tumour-resident Lgr5+ stem-like cells are critical to the initiation and maintenance of tumour burden, and are obligatory for the establishment of metastases. These models will be invaluable for deriving clinically-relevant mechanistic insights into cancer progression and as pre-clinical models for evaluating novel therapeutics.

2021-11-26 | GSE184613 | GEO

Apc-mutants act as supercompetitors in intestinal tumour initiation

Project description:Almost all colorectal cancers (CRC) present with mutations in the Apc gene, leading to unrestrained Wnt activation and the initiation of tumour development. We previously reported the competitive benefit of Apc-mutant intestinal stem cells (ISCs) within the crypt, however, the mechanism by which they outcompete their wild type (WT) neighbours remained elusive. Here, we studied the effect of Apc-mutants using an in vitro culture system of WT (Lgr5-CreErt2) and Apc-/- (Lgr5-CreErt2;Apcfl/fl) organoids . The expression patterns of WT and Apc-/- organoids revealed significant upregulation in specific secreted Wnt antagonists Notum, Wif1 and Dkk2. Furthermore, we studied the effect of the secreted antagonist by treating WT organoids with either WT or Apc-/- conditioned medium (CM) for 48 hours and observed a significant decrease in stem cell markers and an increase in goblet cell markers. We report that Apc-mutants act as bona fide supercompetitors by secreting Wnt antagonists that result in active differentiation of WT ISCs.

2021-03-25 | GSE144325 | GEO

The role of Lgr5 intestinal cancer stem cells in tumour initiation, progression and metastasis

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-03-29 | GSE92966 | GEO

Apc-mutants act as supercompetitors in intestinal tumour initiation

Project description:Apc-mutants act as supercompetitors in intestinal tumour initiation

| PRJNA603370 | ENA

Crypt density and recruited enhancers underlie intestinal tumour initiation

Project description:Crypt density and recruited enhancers underlie intestinal tumour initiation

| PRJNA1007869 | ENA

Crypt density and recruited enhancers underlie intestinal tumour initiation

Project description:Crypt density and recruited enhancers underlie intestinal tumour initiation

| PRJNA1181901 | ENA

Crypt density and recruited enhancers underlie intestinal tumour initiation

Project description:Crypt density and recruited enhancers underlie intestinal tumour initiation

| PRJNA1007859 | ENA

KRAS allelic imbalance drives a MAPK dependent tumour initiation programme inefficient at rewiring the tumour microenvironment to provoke metastasis

Project description:KRAS allelic imbalance drives a MAPK dependent tumour initiation programme inefficient at rewiring the tumour microenvironment to provoke metastasis

| PRJNA797286 | ENA

Crypt density and recruited enhancers underlie intestinal tumour initiation [Bisulfite-seq]

Project description:Crypt density and recruited enhancers underlie intestinal tumour initiation [Bisulfite-seq]

| PRJNA1007883 | ENA

Crypt density and recruited enhancers underlie intestinal tumour initiation [ATAC-seq]

Project description:Crypt density and recruited enhancers underlie intestinal tumour initiation [ATAC-seq]

| PRJNA1007884 | ENA